Abstract: The present invention relates to chemical-pharmaceutical industry and medicine. The present invention relates to N-[3-(4-nitrophenylamino)-indole-2-ilmethylene]aminoguanidine hydrochloride of formula (2) having anti-inflammatory and chondroprotective activity. The compound does not exhibit adverse effects.
Type:
Application
Filed:
March 11, 2011
Publication date:
January 10, 2013
Applicant:
INPHARMA
Inventors:
Svetlana Yurevna Ryabova, Valery Aleksandrovich Parshin, Marina Alekseevna Kalinkina, Vladimir Grigorevich Granik, Vladimir Vladimirovich Granik, Nikita Borisovich Grigoriev, Viktoriya Isaakovna Levina, Elena Konstantinovna Panisheva, Sergey Anatolevich Zaycev
Abstract: The invention includes a nonformulated, low-dose hypocholesterolemic composition comprising soya proteins and ?-sitosterol, wherein the soya proteins and the ?-sitosterol are present in a weight ratio of about 6±1.5 of the soya proteins to about 1±0.2 of the ?-sitosterol; and wherein the composition is made up as an optimal daily dose of only the two components for adults or for children.
Abstract: The new pharmaceutical compositions contain, apart from one or more active ingredient(s), between 0.01 and 60% w/w of the compounds of formula I with n and m>18 and <46 and with molecular weights between ˜600 and ˜8000 for the enhancement of absorption of the active ingredient(s). Moreover, such compositions may contain also between 0.01 and 20% w/w of Phosphatidylcholine.
Abstract: Description of pharmaceutical or cosmetic compositions aimed at improving the local microcirculation of the penis for chronic topical treatment of vascular impotence due to vascular causes, with main impairment of the arterial-arteriolar afferents of the cavernous bodies. The new pharmacological properties of the complex between PGE1 and/or Troxerutine with Phosphatidylcholine are administered locally on the skin of the penis; the activity is obtained using the T.E.B. system according to Curri.